biOasis Technologies Ord Shs BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

GREY:BIOAF - Post by User

biOasis Technologies Ord Shs > The next step in the saga!

<< Previous

Bullboard Posts

Next >>

Comment by Boomskidon Jan 25, 2023 2:04pm

136 Views

Post# 35245802

RE:RE:RE:The next step in the saga!

We've discussed most of the issues, consequences, strategies, possibilities and opportunities, zwerp2000. You've been too busy yapping to read it, let alone comprehend it. You could have even been helpful. You still can, but we don't need half-hour complaints about bad things are.

Don't bother asking us to start all over because of your inadeqacies and bad temper. Unlike some of the others, I'd like to get along with you but you're making it a worthless endeavour.

jd

<< Previous

Bullboard Posts

Next >>

Three micro-cap stocks on an upswing worth riding